Accordingly, HML2 expression has been studied in various cancer types such as lung cancer, germ cell tumors, prostate cancer, melanoma, etc. (Wang-Johanning et al., 2007; Chang et al., 2019; Salavatiha et al., 2020; Gao et al., 2021). The gene discussed is CLEC10A; the disease is cancer.